Cargando…

P963: EVOLUTION OF TREATMENT PATTERNS AND OVERALL SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING A SECOND LINE OF THERAPY BETWEEN 2012 AND 2020: ANALYSIS OF THE PREAMBLE COHORT

Detalles Bibliográficos
Autores principales:	Kuter, D., Goldschmidt, H., Cella, D., Petrucci, M. T., Moreau, P., Durie, B., Juarez-Garcia, A., Trong, L., Gu, J., Hernandez Rivera, G., Dhanasiri, S., Marshall, T., Wang, J., Lacoin, L., Ramasamy, K., Vij, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430142/ http://dx.doi.org/10.1097/01.HS9.0000846720.60768.ed

Ejemplares similares

P945: REAL-WORLD CLINICAL OUTCOMES AMONG TRIPLE-CLASS EXPOSED RELAPSED REFRACTORY MULTIPLE MYELOMA PATIENTS IN US AND EUROPE: A PREAMBLE REGISTRY STUDY
por: Ramasamy, Karthik, et al.
Publicado: (2023)

Preamble
por: Gautam, Shiv, et al.
Publicado: (2022)

Preamble
por: Gautam, Shiv, et al.
Publicado: (2022)

Preamble to these proceedings
por: Johnsen, Kjell
Publicado: (1985)

Preamble of the Clinical Practice Guidelines
por: Gautham, Shiv, et al.
Publicado: (2017)

PREAMBLE OF THE CLINICAL PRACTICE GUIDELINES FOR ELDERLY
por: Gautam, Shiv, et al.
Publicado: (2018)

Preamble for Clinical Practice Guidelines for Psychotherapies
por: Gautam, Shiv, et al.
Publicado: (2020)

Editors’ Preamble to The Journal of Cardiovascular Aging
por: Marian, Ali J., et al.
Publicado: (2021)

Preamble to the Special Edition Plants and Microgravity
por: Kordyum, Elizabeth, et al.
Publicado: (2023)

Preamble to the 2015 SITC immunotherapy biomarkers taskforce
por: Butterfield, Lisa H, et al.
Publicado: (2015)

Preamble and Constitution of the Rock River Medical Society
Publicado: (1846)

P963: EXTRAMEDULLARY MULTIPLE MYELOMA: CLINICAL CHARACTERISTICS, IMPACT, AND OUTCOMES IN A COHORT OF PATIENTS IN MEXICO
por: Llorente Chávez, Amaya, et al.
Publicado: (2023)

Preamble to Remarks on the 1961 Budget (by the Director-General of CERN)
Publicado: (1960)

EDITORIAL PREAMBLE:Molecular biology tools in clinical diagnosis
por: PERKINS, Dana, et al.
Publicado: (2007)

963 Can telemedicine improve postpartum access to care?
por: Sagaram, Deepika, et al.
Publicado: (2021)

Preamble for Clinical Practice Guidelines for Child and Adolescent Psychiatric Disorders
por: Gautam, Shiv, et al.
Publicado: (2019)

Preamble and Resolutions in Regard to Cholera, by the New York Academy of Medidine
Publicado: (1866)

963. Antibiotic Talk on TikTok: An Opportunity for Patient Education?
por: Biehle, Lauren R, et al.
Publicado: (2021)

Efficient Preamble Design Technique for Millimeter-Wave Cellular Systems with Beamforming
por: Han, Dae Geun, et al.
Publicado: (2016)

Preamble-Based Adaptive Channel Estimation for IEEE 802.11p †
por: Choi, Joo-Young, et al.
Publicado: (2019)

PAX-MAC: A Low Latency Anycast Protocol with Advanced Preamble †
por: Heimfarth, Tales, et al.
Publicado: (2020)

Preamble Design and Collision Resolution in a Massive Access IoT System
por: Zhong, Ailing, et al.
Publicado: (2021)

Preamble for Clinical Practice Guidelines for Psychiatric Emergencies and Brain Stimulation Techniques
por: Gautam, Shiv, et al.
Publicado: (2023)

963. Extragenital Chlamydia and Gonorrhea Among Females Visiting an STD Clinic
por: Maynard, Michaela, et al.
Publicado: (2019)

963. Non-Invasive Detection of Cardiovascular Risk in People Living with HIV in Miami
por: Salguero, Douglas, et al.
Publicado: (2020)

Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study
por: Cella, David, et al.
Publicado: (2018)

Optimal sequencing in the management of relapsed/refractory myeloma patients
por: Moreau, Philippe
Publicado: (2018)

Characterization of GSK′963: a structurally distinct, potent and selective inhibitor of RIP1 kinase
por: Berger, SB, et al.
Publicado: (2015)

The Class I HDAC inhibitor RGFP963 enhances consolidation of cued fear extinction
por: Bowers, Mallory E., et al.
Publicado: (2015)

A systematic approach to biomarker discovery; Preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers"
por: Butterfield, Lisa H, et al.
Publicado: (2008)

Preamble from the Guest Editor of Special Issue “DFT Quantum-Chemical Calculation of Metal Clusters”
por: Mikhailov, Oleg V.
Publicado: (2021)

In Memoriam—Henry Noah Martin, M. D.: Preamble and Resolutions by the Bœnninghausen Medical Club, of Philadelphia
Publicado: (1889)

An Energy-Efficient LoRa Multi-Hop Protocol through Preamble Sampling for Remote Sensing
por: Leenders, Guus, et al.
Publicado: (2023)

P958: REAL-LIFE CURRENT STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: SUBGROUP ANALYSES FROM THE LOCOMMOTION STUDY
por: Einsele, H., et al.
Publicado: (2022)

Mass in E flat major, D. 950 ; Tantum ergo, D. 962 ; Offertorium, D. 963
por: Schubert, Franz, 1797-1828
Publicado: (1988)

Helicobacter pylori Seropositivity among 963 Japanese Brazilians According to Sex, Age, Generation, and Lifestyle Factors
por: Ito, Lucy S., et al.
Publicado: (2001)

PB2012: A PHASE 2 MULTIARM STUDY OF MAGROLIMAB COMBINATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Paul, B., et al.
Publicado: (2022)

Response to: Olry de Labry Lima A et al., Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant hematopoietic progenitor cells
por: Dhanasiri, Sujith
Publicado: (2019)

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results
por: Richardson, Paul G., et al.
Publicado: (2018)

PB2093: OVERALL SURVIVAL IN RELAPSED-REFRACTORY MYELOMA PATIENTS DEPENDS ON CIRCULATING PLASMA CELLS QUANTITATION
por: Parrinello, Nunziatina Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_du54ph1q5mr3tinjdr8tk7gbvj